Elevated expression of the interleukin 4 receptor in carcinoma: a target for immunotherapy?
Studies using monoclonal antibody MR6, which is thought to bind to the interleukin-4 growth factor receptor (IL-4R), indicate that IL-4R molecules are upregulated in tumours of epithelial origin and that radiolabelled MR6 is effective as an in vivo tumour imaging agent. Immunohistochemical analysis...
| Main Authors: | , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Nature Publishing Group
1989
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246718/ |